Joshi D, Quadri M, Gangane N, Joshi R, Gangane N (2009). "Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women". ProS One. 4 (12): e8180., PMC2782138, PMID19997605, doi:10.1371/journal.pone.0008180.
He JR, Chen LJ, Su Y, Cen YL, Tang LY, Yu DD, Chen WQ, Wang SM, Song EW, Ren ZF (2012). "Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-γ on breast cancer risk". The Journal of Infectious Disease. 205 (1): 64-71., PMID22095765, doi:10.1093/infdis/jir710.
Peng J, Wang T, Zhu H, Guo J, Li K, Yao Q, Lv Y, Zhang J, He C, Chen J, Wang L, Jin Q (2014). "Multiplex PCR/mass spectrometry screening of biological carcinogenic agents in human mammary tumors". Journal of Clinical Virology. 61 (2): 255-9., PMID25088618, doi:10.1016/j.jcv.2014.07.010.
Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, Buisson M, Gérard H, Reymond MO, Seigneurin JM, Martin PM (2001). "Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas". British Journal of Cancer. 84 (6): 783-90., PMC2363823, PMID11259092, doi:10.1054/bjoc.2000.1672.
Hachana M, Amara K, Ziadi S, Romdhane E, Gacem RB, Trimeche M (2011). "Investigation of Epstein-Barr virus in breast carcinomas in Tunisia". Pathology - Research and Practice. 207 (11): 695-700., PMID22024152, doi:10.1016/j.prp.2011.09.007.
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM (2011). "Epstein–Barr virus as a marker of biological aggressiveness in breast cancer". British Journal of Cancer. 104(2): 332-7., PMC3031896, PMID21179039, doi:10.1038/sj.bjc.6606048.
Marrão G, Habib M, Paiva A, Bicout D, Fallecker C, Franco S, Fafi-Kremer S, Simões da Silva T, Morand P, Freire de Oliveira C, Drouet E (2014). "Epstein–Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-alpha/IFN-gamma response". BMC Cancer. 14: 665., PMC4171567, PMID25213133, doi:10.1186/1471-2407-14-665.
Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotirious C, Dittmer DP, Fingeroth JD, Wulf GM (2016). "Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation". EBioMedicine. 9: 148-60., PMC4972522, PMID27333046, doi:10.1016/j.ebiom.2016.05.025.
Kuhl CK, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007; 370(9586): 485-92., doi:10.1016/S0140-6736(07)61232-X
Joshi D, Quadri M, Gangane N, Joshi R, Gangane N (2009). "Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women". ProS One. 4 (12): e8180., PMC2782138, PMID19997605, doi:10.1371/journal.pone.0008180.
He JR, Chen LJ, Su Y, Cen YL, Tang LY, Yu DD, Chen WQ, Wang SM, Song EW, Ren ZF (2012). "Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-γ on breast cancer risk". The Journal of Infectious Disease. 205 (1): 64-71., PMID22095765, doi:10.1093/infdis/jir710.
Peng J, Wang T, Zhu H, Guo J, Li K, Yao Q, Lv Y, Zhang J, He C, Chen J, Wang L, Jin Q (2014). "Multiplex PCR/mass spectrometry screening of biological carcinogenic agents in human mammary tumors". Journal of Clinical Virology. 61 (2): 255-9., PMID25088618, doi:10.1016/j.jcv.2014.07.010.
Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, Buisson M, Gérard H, Reymond MO, Seigneurin JM, Martin PM (2001). "Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas". British Journal of Cancer. 84 (6): 783-90., PMC2363823, PMID11259092, doi:10.1054/bjoc.2000.1672.
Hachana M, Amara K, Ziadi S, Romdhane E, Gacem RB, Trimeche M (2011). "Investigation of Epstein-Barr virus in breast carcinomas in Tunisia". Pathology - Research and Practice. 207 (11): 695-700., PMID22024152, doi:10.1016/j.prp.2011.09.007.
Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995). "Epstein–Barr virus in epithelial cell tumors: a breast cancer study". Cancer Research. 55 (1): 39-45., PMID7805038, full text.
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM (2011). "Epstein–Barr virus as a marker of biological aggressiveness in breast cancer". British Journal of Cancer. 104(2): 332-7., PMC3031896, PMID21179039, doi:10.1038/sj.bjc.6606048.
Marrão G, Habib M, Paiva A, Bicout D, Fallecker C, Franco S, Fafi-Kremer S, Simões da Silva T, Morand P, Freire de Oliveira C, Drouet E (2014). "Epstein–Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-alpha/IFN-gamma response". BMC Cancer. 14: 665., PMC4171567, PMID25213133, doi:10.1186/1471-2407-14-665.
Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotirious C, Dittmer DP, Fingeroth JD, Wulf GM (2016). "Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation". EBioMedicine. 9: 148-60., PMC4972522, PMID27333046, doi:10.1016/j.ebiom.2016.05.025.
Joshi D, Quadri M, Gangane N, Joshi R, Gangane N (2009). "Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women". ProS One. 4 (12): e8180., PMC2782138, PMID19997605, doi:10.1371/journal.pone.0008180.
Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, Buisson M, Gérard H, Reymond MO, Seigneurin JM, Martin PM (2001). "Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas". British Journal of Cancer. 84 (6): 783-90., PMC2363823, PMID11259092, doi:10.1054/bjoc.2000.1672.
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM (2011). "Epstein–Barr virus as a marker of biological aggressiveness in breast cancer". British Journal of Cancer. 104(2): 332-7., PMC3031896, PMID21179039, doi:10.1038/sj.bjc.6606048.
Marrão G, Habib M, Paiva A, Bicout D, Fallecker C, Franco S, Fafi-Kremer S, Simões da Silva T, Morand P, Freire de Oliveira C, Drouet E (2014). "Epstein–Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-alpha/IFN-gamma response". BMC Cancer. 14: 665., PMC4171567, PMID25213133, doi:10.1186/1471-2407-14-665.
Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotirious C, Dittmer DP, Fingeroth JD, Wulf GM (2016). "Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation". EBioMedicine. 9: 148-60., PMC4972522, PMID27333046, doi:10.1016/j.ebiom.2016.05.025.